352 related articles for article (PubMed ID: 23772948)
1. Targeting inflammatory pathways in myocardial infarction.
Christia P; Frangogiannis NG
Eur J Clin Invest; 2013 Sep; 43(9):986-95. PubMed ID: 23772948
[TBL] [Abstract][Full Text] [Related]
2. The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities.
Frangogiannis NG
J Cardiovasc Pharmacol; 2014 Mar; 63(3):185-95. PubMed ID: 24072174
[TBL] [Abstract][Full Text] [Related]
3. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.
Prabhu SD; Frangogiannis NG
Circ Res; 2016 Jun; 119(1):91-112. PubMed ID: 27340270
[TBL] [Abstract][Full Text] [Related]
4. The inflammatory response in myocardial injury, repair, and remodelling.
Frangogiannis NG
Nat Rev Cardiol; 2014 May; 11(5):255-65. PubMed ID: 24663091
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the inflammatory response in cardiac repair.
Frangogiannis NG
Circ Res; 2012 Jan; 110(1):159-73. PubMed ID: 22223212
[TBL] [Abstract][Full Text] [Related]
6. The immune system and cardiac repair.
Frangogiannis NG
Pharmacol Res; 2008 Aug; 58(2):88-111. PubMed ID: 18620057
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 in cardiac injury, repair, and remodeling: pathophysiologic and translational concepts.
Frangogiannis NG
Discoveries (Craiova); 2015; 3(1):. PubMed ID: 26273700
[TBL] [Abstract][Full Text] [Related]
8. CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response.
Huebener P; Abou-Khamis T; Zymek P; Bujak M; Ying X; Chatila K; Haudek S; Thakker G; Frangogiannis NG
J Immunol; 2008 Feb; 180(4):2625-33. PubMed ID: 18250474
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.
Huang S; Frangogiannis NG
Br J Pharmacol; 2018 May; 175(9):1377-1400. PubMed ID: 29394499
[TBL] [Abstract][Full Text] [Related]
10. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling.
Bujak M; Ren G; Kweon HJ; Dobaczewski M; Reddy A; Taffet G; Wang XF; Frangogiannis NG
Circulation; 2007 Nov; 116(19):2127-38. PubMed ID: 17967775
[TBL] [Abstract][Full Text] [Related]
11. IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium.
Saxena A; Chen W; Su Y; Rai V; Uche OU; Li N; Frangogiannis NG
J Immunol; 2013 Nov; 191(9):4838-48. PubMed ID: 24078695
[TBL] [Abstract][Full Text] [Related]
12. Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities.
Hilgendorf I; Frantz S; Frangogiannis NG
Circ Res; 2024 Jun; 134(12):1718-1751. PubMed ID: 38843294
[TBL] [Abstract][Full Text] [Related]
13. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study.
Faxon DP; Gibbons RJ; Chronos NA; Gurbel PA; Sheehan F;
J Am Coll Cardiol; 2002 Oct; 40(7):1199-204. PubMed ID: 12383565
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling.
Zymek P; Nah DY; Bujak M; Ren G; Koerting A; Leucker T; Huebener P; Taffet G; Entman M; Frangogiannis NG
Cardiovasc Res; 2007 May; 74(2):313-22. PubMed ID: 17188669
[TBL] [Abstract][Full Text] [Related]
15. The role of autophagy emerging in postinfarction cardiac remodelling.
Kanamori H; Takemura G; Goto K; Maruyama R; Tsujimoto A; Ogino A; Takeyama T; Kawaguchi T; Watanabe T; Fujiwara T; Fujiwara H; Seishima M; Minatoguchi S
Cardiovasc Res; 2011 Jul; 91(2):330-9. PubMed ID: 21406597
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of Myocardial Infarction.
Frangogiannis NG
Compr Physiol; 2015 Sep; 5(4):1841-75. PubMed ID: 26426469
[TBL] [Abstract][Full Text] [Related]
17. Endogenous IRAK-M attenuates postinfarction remodeling through effects on macrophages and fibroblasts.
Chen W; Saxena A; Li N; Sun J; Gupta A; Lee DW; Tian Q; Dobaczewski M; Frangogiannis NG
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2598-608. PubMed ID: 22995519
[TBL] [Abstract][Full Text] [Related]
18. The inflammatory response in myocardial infarction.
Frangogiannis NG; Smith CW; Entman ML
Cardiovasc Res; 2002 Jan; 53(1):31-47. PubMed ID: 11744011
[TBL] [Abstract][Full Text] [Related]
19. New Therapies to Modulate Post-Infarction Inflammatory Alterations in the Myocardium: State of the Art and Forthcoming Applications.
Clerc OF; Haaf P; Buechel RR; Gaemperli O; Zellweger MJ
Curr Radiopharm; 2021; 14(3):273-299. PubMed ID: 33302861
[TBL] [Abstract][Full Text] [Related]
20. Chemokines in the ischemic myocardium: from inflammation to fibrosis.
Frangogiannis NG
Inflamm Res; 2004 Nov; 53(11):585-95. PubMed ID: 15693606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
